Carillon Tower Advisers’s Pfizer PFE Stock Holding History

Carillon Tower Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$7.17M	Sell	194,695 -307,276	-61%	-$11.3M	0.04%	363
2020 Q3	$17.5M	Sell	501,971 -47,533	-9%	-$1.67M	0.23%	162
2020 Q2	$17M	Sell	549,504 -25,047	-4%	-$851K	0.13%	219
2020 Q1	$17.3M	Sell	574,551 -23,051	-4%	-$785K	0.17%	193
2019 Q4	$22.2M	Sell	597,602 -11,683	-2%	-$416K	0.15%	238
2019 Q3	$20.8M	Buy	609,285 +214,384	+54%	+$7.8M	0.14%	239
2019 Q2	$16.2M	Buy	394,901 +17,709	+5%	+$703K	0.11%	277
2019 Q1	$15.2M	Sell	377,192 -109,298	-22%	-$4.38M	0.11%	279
2018 Q4	$20.1M	Buy	486,490 +35,781	+8%	+$1.49M	0.17%	216
2018 Q3	$18.8M	Sell	450,709 -143,843	-24%	-$5.54M	0.14%	242
2018 Q2	$20.5M	Sell	594,552 -10,187	-2%	-$348K	0.16%	212
2018 Q1	$20.1M	Sell	604,739 -23,997	-4%	-$825K	0.16%	207
2017 Q4	$21.6M	Buy	+628,736	New	+$21.4M	0.23%	173

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Carillon Tower Advisers's PFE Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Pfizer (PFE) stake by 61% in Q4 2020, selling an estimated $11.3M and leaving 194,695 shares worth $7.17M. The position accounts for 0.04% of the portfolio, ranked #363.

Carillon Tower Advisers first reported a position in PFE in Q4 2017 and has held it in 13 quarters since. The position peaked at $22.2M in Q4 2019. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Carillon Tower Advisers held 194,695 shares of Pfizer worth $7.17M as of Q4 2020.
Carillon Tower Advisers sold 307,276 Pfizer shares in Q4 2020, an estimated $11.3M.
Pfizer made up 0.04% of Carillon Tower Advisers's portfolio in Q4 2020, its #363 holding.
Carillon Tower Advisers first reported a position in Pfizer in Q4 2017 and has held it in 13 quarters since.
Carillon Tower Advisers's Pfizer position peaked at $22.2M in Q4 2019.
2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.